MNPR
Monopar Therapeutics Inc. - Common Stock (MNPR)
$00
About Monopar Therapeutics Inc. - Common Stock (MNPR)
Monopar Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in developing proprietary therapeutics for cancer patients. It also focuses on building a drug development pipeline through the licensing, and acquisition of therapeutics in late preclinical and clinical development stages. The company was founded by Chandler Drew Robinson, Christopher M. Starr and Andrew P. Mazar in December 2014 and is headquartered in Wilmette, IL.
Details
Daily high
$34.40
Daily low
$32.95
Price at open
$34.40
52 Week High
$54.30
52 Week Low
$1.72
Market cap
201.8M
Dividend yield
0.00%
Volume
15,170
Avg. volume
24,797
P/E ratio
-8.28
Monopar Therapeutics Inc. - Common Stock News
Details
Daily high
$34.40
Daily low
$32.95
Price at open
$34.40
52 Week High
$54.30
52 Week Low
$1.72
Market cap
201.8M
Dividend yield
0.00%
Volume
15,170
Avg. volume
24,797
P/E ratio
-8.28